We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+3.65%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$7.81M
Cap. Flow
-$11.3M
Cap. Flow %
-11.27%
Top 10 Hldgs %
11.69%
Holding
238
New
12
Increased
100
Reduced
117
Closed
1

Top Buys

Rank Stock Value
1
ARHS icon
Arhaus
ARHS
+$228K
2
AR icon
Antero Resources
AR
+$208K
3
MTDR icon
Matador Resources
MTDR
+$203K
4
SSTK icon
Shutterstock
SSTK
+$194K
5
EXE
Expand Energy Corp
EXE
+$188K

Top Sells

Rank Stock Value
1
ELF icon
e.l.f. Beauty
ELF
+$919K
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$772K
3
CPRX
Catalyst Pharmaceutical
CPRX
+$637K
4
ENPH icon
Enphase Energy
ENPH
+$535K
5
META icon
Meta Platforms (Facebook)
META
+$528K

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Healthcare 26.32%
3 Consumer Discretionary 12.34%
4 Industrials 8.94%
5 Financials 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLS
51
DELISTED
Apellis Pharmaceuticals
APLS
$604K 0.6%
13,959
+659
+5% +$39K
NTLA icon
52
Intellia Therapeutics
NTLA
$1.49B
$586K 0.58%
11,954
+464
+4% +$28.8K
SHAK icon
53
Shake Shack
SHAK
$2.53B
$584K 0.58%
11,511
+1,823
+19% +$87.5K
WWE
54
DELISTED
World Wrestling Entertainment
WWE
$583K 0.58%
7,568
-2,112
-22% -$144K
TRUP icon
55
Trupanion
TRUP
$1.07B
$581K 0.58%
9,819
+432
+5% +$29K
WIRE
56
DELISTED
Encore Wire Corp
WIRE
$577K 0.57%
3,922
-479
-11% -$58.3K
NVDA icon
57
NVIDIA
NVDA
$4.86T
$576K 0.57%
47,460
-23,780
-33% -$376K
IRMD icon
58
iRadimed
IRMD
$1.16B
$575K 0.57%
20,370
+1,214
+6% +$42.3K
MD icon
59
Pediatrix Medical
MD
$2.18B
$575K 0.57%
36,898
+500
+1% +$10.1K
SAH icon
60
Sonic Automotive
SAH
$2.89B
$572K 0.57%
11,134
-5,783
-34% -$262K
MDGL icon
61
Madrigal Pharmaceuticals
MDGL
$10.8B
$570K 0.57%
8,162
– –
MXL icon
62
MaxLinear
MXL
$6.06B
$568K 0.57%
16,103
+481
+3% +$17.8K
ONEW icon
63
OneWater Marine
ONEW
$204M
$564K 0.56%
17,892
+2,060
+13% +$75.3K
AMED
64
DELISTED
Amedisys
AMED
$563K 0.56%
6,390
-1,333
-17% -$159K
BEAM icon
65
Beam Therapeutics
BEAM
$2.63B
$554K 0.55%
11,697
+2,766
+31% +$158K
VET icon
66
Vermilion Energy
VET
$1.82B
$549K 0.55%
28,457
+4,794
+20% +$113K
FTNT icon
67
Fortinet
FTNT
$119B
$547K 0.54%
11,141
-2,285
-17% -$124K
SNPS icon
68
Synopsys
SNPS
$74.4B
$546K 0.54%
1,787
-880
-33% -$298K
MTDR icon
69
Matador Resources
MTDR
$6.2B
$544K 0.54%
7,906
+3,754
+90% +$203K
AN icon
70
AutoNation
AN
$7.11B
$541K 0.54%
4,482
-1,998
-31% -$234K
AR icon
71
Antero Resources
AR
$11.1B
$523K 0.52%
14,811
+5,627
+61% +$208K
EB
72
DELISTED
Eventbrite
EB
$520K 0.52%
71,381
+2,673
+4% +$22.5K
WTI icon
73
W&T Offshore
WTI
$534M
$519K 0.52%
71,754
+19,103
+36% +$104K
CRM icon
74
Salesforce
CRM
$151B
$502K 0.5%
3,487
-878
-20% -$149K
HI
75
DELISTED
Hillenbrand
HI
$498K 0.5%
10,358
+403
+4% +$17K
1 2
3
4 5

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Capital Impact Advisors held 238 positions worth $100M, down 7.2% from $108M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Capital Impact Advisors withdrew a net $11.3M in Q3 2022, closing 1 position and reducing 117 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $772K position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Capital Impact Advisors opened a new position in Ginkgo Bioworks worth $118K.

  • Capital Impact Advisors's largest Q3 2022 buy was Ginkgo Bioworks: 1,374 shares worth $118K.
  • Capital Impact Advisors added most to Arhaus in Q3 2022, an estimated $228K increase.
  • Capital Impact Advisors's biggest Q3 2022 reduction was e.l.f. Beauty, cutting an estimated $919K.
  • Capital Impact Advisors fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $772K.
  • Capital Impact Advisors's ten largest holdings make up 12% of its $100M portfolio in Q3 2022.
  • Capital Impact Advisors opened 12 new positions and closed 1 in Q3 2022.
  • Capital Impact Advisors's portfolio value fell 7.2% quarter-over-quarter to $100M.

Based on Capital Impact Advisors's 13F filing for Q3 2022, filed 22 Nov 2022.